SLE AN AYURVEDIC APPROACH
Abstract
Auto immunity is defined as the state in which the immune system react against the body’s own normal components, producing disease or functional change. There are mainly two types of autoimmunity - Organ specific and Organ nonspecific type.
SLE is one of the organ nonspecific autoimmune disorder. Prevalence is about 20 to 200 per 100000 persons in India. Genetic, environmental, and immunological factors are responsible for the development of this disease. SLE is a disease of unknown etiology with a variety of presenting complaints. The pathology in SLE is related to deposit of immune complexes in various organs, which triggers complement and other mediators of inflammation. Symptoms may vary from person to person. It is a multisystem involving disease, affecting the internal organs like kidney, heart, liver…etc, leading to many complications and ultimately death. The general symptoms include fever, malaise, arthralgia, myalgia, headache, weight loss and loss of appetite. Treatment options depend upon the organ systems involved and severity of symptoms.
In Ayurveda, we can consider SLE as a bahudoshaja vyadhi mainly having vidahitwa and dhatupaka. Generally, the vataraktha line of management is adopted in this condition, when the symptoms of SLE manifest on the skin we can adopt uthana line of management, when it affects the multiple systems according to the severity we can adopt gambhira line of management. According to the roga- rogi bala, we can choose appropriate medications.
Key words: SLE, Vataraktha
References
Johnson AE, Gordon C, Palmer RG, Bacon PA, The prevalence and incidence of systemic lupus erythematosus in Birmingham, England: Relationship to ethnicity and country of birth, Arthritis Rheum. 38 (1995) 551–558. doi: 10.1002/art.1780380415. [PubMed] [CrossRef] [Google Scholar]
Krishnan E, Hubert HB, Ethnicity and mortality from systemic lupus erythematosus in the US, Ann. Rheum. Dis 65 (2006) 1500–1505. doi: 10.1136/ard.2005.040907. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
Mukkera S, Mannem M, Chamarti K, Pillarisetty L, Vulasala SS, Alahari L, Ammu A, Mukkera A, Vadlapatla RK. Systemic Lupus Erythematosus-Associated Serositis Managed With Intravenous Belimumab: A Case Report. Cureus. 2022 Feb;14(2):e22639. [PMC free article] [PubMed]
Skudalski L, Shahriari N, Torre K, Santiago S, Bibb L, Kodomudi V, Grant-Kels JM, Lu J. Emerging therapeutics in the management of connective tissue disease. Part I. Lupus erythematosus and Sjögren syndrome. J Am Acad Dermatol. 2022 Jul;87(1):1-18. [PubMed]
Scheen M, Adedjouma A, Esteve E, Buob D, Abisror N, Planche V, Fain O, Boffa JJ, De Seigneux S, Mekinian A, Haidar F. Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management. Autoimmun Rev. 2022 May;21(5):103072. [PubMed]
Scheen M, Adedjouma A, Esteve E, Buob D, Abisror N, Planche V, Fain O, Boffa JJ, De Seigneux S, Mekinian A, Haidar F. Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management. Autoimmun Rev. 2022 May;21(5):103072. [PubMed]
Scheen M, Adedjouma A, Esteve E, Buob D, Abisror N, Planche V, Fain O, Boffa JJ, De Seigneux S, Mekinian A, Haidar F. Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management. Autoimmun Rev. 2022 May;21(5):103072. [PubMed]
Aringer M, Costenbader K, Johnson SR. Assessing the EULAR/ACR classification criteria for patients with systemic lupus erythematosus. Expert Rev Clin Immunol. 2022 Feb;18(2):135-144. [PubMed]
Aringer M, Costenbader K, Johnson SR. Assessing the EULAR/ACR classification criteria for patients with systemic lupus erythematosus. Expert Rev Clin Immunol. 2022 Feb;18(2):135-144. [PubMed]
Sternhagen E, Bettendorf B, Lenert A, Lenert PS. The Role of Clinical Features and Serum Biomarkers in Identifying Patients with Incomplete Lupus Erythematosus at Higher Risk of Transitioning to Systemic Lupus Erythematosus: Current Perspectives. J Inflamm Res. 2022;15:1133-1145. [PMC free article] [PubMed]
Vaidya Jadhavji T.A., editor. Charaka Samhita of Acharya Charaka, Chikitsa Sthana, Vatashonita chikitsaa, 29th chapter, verse 27, 35, and 45. 2nd ed. Chaukambha Surabharathi Prakashan; Varanasi: 2005. p. 629. [Google Scholar
Agnivesha, Charaka Samhita, Ayurveda- Dipika commentary by Chakrapanidutta, revised ed., Chikitsa Sthana (3:50 - 52), pg. 403, Chaukhambha Surbharati Prakashan, Varanasi, (2005).
